Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah not sure either. Like I said hopefully it will improve going forward.
Yep, no problem. They look to be pretty legit and get all 5* reviews on Google. The website/product are obviously not quite ready yet to sell, so hopefully it will improve when they are ready for orders.
Looking into NPI initially, it seemed they had some really bad reviews from everywhere, including the BBB. However when reading some of the complaints/reviews, it was all about customers receiving a bunch of spam from them once they went to the site and signed up with their email address. According to NPI, they had been hacked, and had nothing to do with it, and even hired counsel to deal with it.
There was a new judge assigned to the case a few months ago I believe, but more than likely it will go to trial. Savov is representing himself and has lost everything so far pertaining to the case.
Not the correct website......
https://synergy11.marketing/
I agree with you but until something major happens, or as you like to say, Charles takes off the muzzle, we are not getting out of this range which includes us going over and above the 200 dma. Delays in the audited fins and IPF have certainly not helped any, especially with the credibility of possible new investors, which is why are accumulation/distribution level remains extremely low, even while we ran from .02 to .08, because that was just another pump. Charles said on Aug 22 that fins were being finalized, and when he says something like that in print I take his word it's going to get done. No clue at this pt what could possibly be left, because in less than 2 months they wouldn't even have to worry about 2020 if they didn't want to.
As far as IPF, and I know they had a labeling issue, but bigger issue imo was production and possibly financing. Which brings me to my next pt. We have 4 or 5 major verticals that we all know about, yet have less than 600k of cash on hand. He has never mentioned raising money via dilution, at least not yet, but at some pt we should see/know how all these things are/will be funded. If privately or with a partnership, you would think that would still need to show up on the fins.
Right. But normally CDEL has been the QB here the longest, but STXG is now the QB and they do back off at times but only to resume and continue to be the QB. Same as you used to always see with CDEL, but at least CDEL will buy/sell unlike STXG.
Yes, they took a break and let it go up til it hit the 200 dma and got rejected of course. Then they resumed.
Yeah definitely could be. I mean when you have a mm selling 80% of the daily vol, and never buying a single share, probably not a dumb thing to do either.
Yeah I've noticed that with PUMA too. But just imagine your the other mm's, and you know that STXG is going to be dumping all day everyday, you can easily help things out to get the sp even lower.
Hey MAGA, obviously since STXG has been back, this is not going anywhere anytime soon. They have millions of shares to dump obviously, and will lower the ASK whenever to get rid of said shares. Problem gets even more compounded when there is very little retail interest to begin with, so the selling of 4-6 million shares a day just puts enormous pressure on the stock.
I completely agree MAGA, and the latest drop in sp over the last couple months was not even a sell off, on extremely low vol. The Discord alone has at least 15% or more of the float locked up so, we get any serious catalyst that gets us back trading in the millions of dollars a day, and we can fly.
Hey MAGA, just getting around to your response, and I think mc for very early stage r&d biotechs with no drugs/revenues are always extremely hard to put a good number on. I believe the value was a little bit less, in the .10-.15 range, but obviously way higher than our current sp. There is no denying the incredibly brutal macro environment that we've been facing the last 6 months, which has brought even co like Intel to a 5 PE. Most of the work is being done in background/silence for numerous of reasons, but the co update on Aug 22 is actually pretty mind boggling to read and reread what is in there. As I've stated before, when Charles says something in print is going to happen, I trust him it will, just like the toxicity study results. Next up will be finally putting an end to the audited financials, which should definitely happen this Q.
Steve is absolutely out of his brain and completely desperate, just another pump to try and lift the sp. There is absolutely nothing patentable or proprietary here whatsoever. What is happening now is similar to what death spiral financing will do, as more and more shares are needing to convert at lower and lower prices. Sitting at .0075 with a conversion discount to market of at least 20% and needing 1.5 million a month is a complete utter disaster, that is literally impossible to get out of, no matter how many units they sell.
Totally agree and that was disappointing to say the least. Hell, look at how much and how many people ordered it from Rosetta in Bulgaria. Even if it was just ordering it online here in the US, revs would be pretty decent considering. Not sure why they were saying we would be in retail stores when we never had enough product here to begin with, and that's what they are supposedly addressing now. So yes the label change issue with the FDA, but the bigger issue was supply imo.
We have to remember though, this is a company of basically 4-6 people, and mistakes are going to be made and timelines are going to be missed. But what I don't see them doing is diluting and lining their pockets like most run OTC companies, in fact quite the opposite. I mean the whole reason to go public is to raise capital usually, so then being very frugal and going the partnership route to pay for the verticals we have now.
99% of all OTC stocks ran from Jan to early Feb, some not to the level of ENZC of course, but even the worst stocks imaginable, like a no bid .0001 and over billions of shares on the ASK @ .0002, went to like .005. A 5-10 bagger was nothing back then, and you could have thrown a dart and made money.
But as far as ENZC, no matter if Charles and Co would have done everything right and everything went there way the last 18 months, there was simply no possible way we were worth 2.5 billion, so the only place to go was down. How far? Well, since we are a r&d biotech with no revs, it's very hard and the mc can fluctuate greatly, as to what we are worth. Hence why these type of growth stocks with no revs have been absolutely hit the hardest in this macro environment. When major stocks that are worth billions are down over 60-80%, you get the idea of market we are dealing with.
So I believe we have enough eyeballs on us, and lots of people that have dipped out and are waiting to jump back in, but they are being very cautious and wanting to see a bottom and something with a little more meat on the bones, ie a equity deal/partnership. Ultimately we will need to break and hold the 50 & 200, then this will give a enormous signal to traders to jump in, until then we are stuck in this pattern and volatility.
I agree, a PR like that to bring in less than 6 million shares in vol when we are only at .035 is pretty crazy. But the charts all suck, the macro environment is probably the worst it could be, if you look at small caps right now, they have basically already priced in a major recession happening right now. So until it show so kinda momentum and can break the long 18 month downtrend, people will remain on the sidelines and wait. Cash is king right now in all markets.
The vol right now is so atrocious MAGA, they were able to bring us down 60% in MC on barely any vol whatsoever. The highest vol stock under a dime in the OTC did 882k $$$ vol, ranking #325 overall. The next highest was like 482k, so nobody is touching the literal pennys right now in the pink sheets. I mean there is no way we should have gone below .03, yet we did. We don't need to get back to Jan 2021 vol, just something a little more respectable and we can move and maintain a sp much higher than this. It's just really retail left here to battle it out, until some of the bigger traders decide to dip their toes back in.
I'm not saying they are naked shorting this, they don't have to with such little vol and no retail buying interest.
ASCM are known shorters and when they arrive that's what they do. Arrived on the scene last week to short when it briefly when above .04, and now looking to cover a lot lower as they steadily push it down.
I've figured we have lost around 37% in value over the last month, while only trading around .06% of the available float, unreal. Retail is completely she'll shocked and there is simply no buying here the past month, unless they drop the price 5-10%. The algos are locked in tight and still super bearish until otherwise.
From up 7% at 1.4 million volume to down 7% at 3.1 million vol. Drop of 14% on only 1.7 million shares, I mean why wouldn't the mm keep lowering it to some support/buying comes in.
No I agree MAGA, and that is the pattern and will continue until something gives. There has just been zero continuity in buying whatsoever here, you get a few buys and it moves a bit, and then just nothing. Liquidity is drying up so fast in the OTC, has to be one of the worst macro environments we can be in at the moment. Of course anything can change at any time, but without much interest, unless we get a major catalyst or something, we are at the mercy of the mm for now.
Yeah they can definitely be a little tricky here but, we know they are dumping on the ASK, and looking to bring the sp lower after someone hits the ASK. And usually there is 2-3 other market makers with big ASKS right behind them to discourage anyone from hitting the ASK, which makes it easy for them to bring it down further on no vol. We are down over 40% or so over the last couple months, but on extremely low vol, so it's not like there is a mass selloff here by any means, just a horrible macro environment and nothing to excite retail traders at the moment. RSI needs to reset and we should see a bounce just off of that, is we have been oversold for awhile.
I agree there is not enough retail interest here yet, I think we would need to see 20-40 million shares with a 80/20 buy/sell ratio, but STXG comes for awhile, like 3-4 weeks then they disappear, done this several times in the past. We haven't had retail interest for 9 months so, hard to say why they are selling.
STXG & ASCM at the top of the ASK pre-market will need to be dealt with before we can move higher.....
.
Of the highlighted ones listed towards the top of the table, what you will experience most always when trying to battle with them is that when these diluting market makers appear, they will usually show 10,000 shares for trade. Countless “Ask Slaps” at that 10,000 do nothing as the count remains 10,000 due to a very deep well of securities to sell. Others listed lower like WDCO, STXG and GLED are brokerage houses which will take share certificates and clear them for low level toxic diluters (those who cut a deal with a company to buy some shares on the cheap).....
Didn't include the list but ASCM was towards the top and STXG was listed lower.
Yep, and now vol has completely dried up, ASK walls firmly in place, mission accomplished.....lol
7.3 million vol in first 30 minutes and we are down, most vol seen here in that timeframe in months......lol
I agree, hell bent to keep this under .04 now at all cost?
It does look like you are right about STXG, there is some entity(s) behind them showing up and dumping on the ASK, but we all know ASCM is definitely a known shorter. Without any retail interest or vol, selling off a few million shares a day can destroy sp right now because of how fragile we are.
Remember MAGA, the OTC has a major issue with naked shorting, and I tend to lean towards that as whats happened here over the last few weeks. Put up the phantom shares/walls on the ASK and drive the price down, since there is no retail interest or support. This is why the quick reaction today to the news. How long can it continue? Who knows.
It is obvious because they just brought this down below .04 over the past few weeks, do you really think they are going to willingly let this run right now? Could be a massive short squeeze if we had the fire power, but it doesn't look that way.
Normally they wait a little bit to jump in, but it's such a bearish market that they have no fear of anyone holding and that we will get continuing vol, that they jumped in almost immediately.
ASCM, on cue comes in like I said when anything starts to run on good vol, and is definitely shorting today.
Believe I get where you are coming from MAGA, but when Charles puts out that testing is ongoing and near completion, and results will be shared as they are completed, I definitely take him at his word that it definitely will happen.
As we all know Dr Chandra was thrust into the role of becoming the face of ENZC, at least in social media circles. Prior to ENZC, he barely posted on Twitter. So I'm just saying I think in that instance, he was kinda put on the spot and probably was just sort of pacifying his audience, and he probably shouldn't have been talking or giving any information out about those studies. Same with the audited financials, should probably not have given the days/weeks comment, but I truly believe that was his belief at that time.
Bottom line for me MAGA, when I look at a lot of other OTC stocks, and try and see what the maximum potential is for their sp or mc, I really don't see anyone in the realm of what ENZC can deliver. Having Samsung Biologics alone as their CDMO, one of the largest in the world, as a OTC pink sheet co should speak volumes alone imo, you simply just don't see it. Clone 3 is where it's at, and that will take time obviously, but as they move through the process and trials, the value of this stock will definitely head higher.
Don't think STXG is retail, but they are definitely bad news, reminds me of ASCM, which are known to arrive basically after any stock has ran hard on decent vol, they are there to short. Imo there are obvious good entry points and bad ones. I'm not calling today a bottom or anything, but buying ENZC at or close to these RSI levels has definitely been profitable if you are looking to swing.
It's hard to argue because it's been a year since we had anything really meaningful, and that was Samsung Biologics, but we are already 2 months in to the toxicity studies, which should take no longer than 4 months max, and this new auditor arrived in July, and that shouldn't take longer than 3 months so, I'm not holding my breath but we should hear some things relatively soon. Not sure how much it will help sp, but we'll get the international publication of that patent on either September 29 or October 6 at the latest.
I tend to agree with you, but imo we are not going to sit in the low to mid .20's RSI, without another massive pump, to about the .07-.08 range, and then with no new news or catalyst, they will start to bring us down again.
I agree MAGA, but why this aggressive this time and at such a low price, makes you wonder if they are loading up knowing that Charles may take off the muzzle soon and drop a bomb. Make it look like a complete toxic turd until the last second, and then pump the living shit out of it when news drops.
The mm here smell blood and have set up their algos to trade just like your seeing. Letting it float up to .04, then bam putting up the wall at .0390 with a major ASK along with STXG with unlimited 10k, and another big ASK at .0391. We'll know they are finished when they disappear or major ASK buys start hitting the tape.
Yeah, we'll see soon enough. Can you imagine if we just had a normal amount of dilution for a OTC co? I mean this is happening with no added shares for basically 2 yrs, which is simply unfathomable.
I also ke
ep reminding myself that we landed Samsung Biologics 11 months ago, and they have to be awfully close or maybe they have submitted that IND application, which would be massive news. And Charles either has deals already in place or lined up for funding, because there has been no mention of raising cash via a capital raise from dilution. It just wouldn't make any sense to not raise money by now unless you already had it in the bag.
So far all the missteps/mistakes that have been made, these guys are definitely not our to screw the shareholders like almost all other OTC pink sheets.